Study Condition(s): Type 2 Diabetes

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Study Alias: GPGF

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT03311724 {{ currentLocaleObject.registryAnchorText }}

Completed Completed

Study Purpose

The purpose of this study is to determine the efficacy of tirzepatide in participants with type 2 diabetes.

Completed Study

The results of this study are not yet available.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study

Gender

Male Female

Age

18 years
75 years

Time Commitment

Your participation could last approximately 12 weeks and include 9 visits to the study center.
  • Participant must have type 2 diabetes (T2D) for at least 6 months
  • Participant taking metformin must be on a stable dose for at least 3 months
  • Participant must not have type 1 diabetes (T1D)
  • Participant must not have used any medication to lower blood sugar other than metformin within 3 months prior to the start of the study
  • Participant must not have had a heart attack, heart failure, or stroke
  • Participant must not have inflammation of the liver (hepatitis), liver disease, or inflammation of the pancreas (pancreatitis)

Where This Study Took Place Tool Tip Icon

13 locations participated
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.